Scholar Rock Holding (SRRK) Return on Capital Employed (2018 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Return on Capital Employed of 99.87% in Q1 2026, up 8.46% quarter-over-quarter from 109.1% in Q4 2025, and down 3280.0% on a YoY basis from 3.14% in Q1 2025.

Scholar Rock Holding (SRRK) Return on Capital Employed (2018 - 2026) Analysis & Trends

Scholar Rock Holding's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 99.87% for Q1 2026.

  • In Q1 2026, Return on Capital Employed fell 3280.0% year-over-year to 99.87%; the TTM figure through Mar 2026 stood at 99.87% (down 3280.0% YoY), while the FY2025 annual figure was 100.12%, down 2728.0% from the prior year.
  • Return on Capital Employed was 99.87% for Q1 2026 at Scholar Rock Holding, up from 109.1% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 34.62% in Q3 2022 to a low of 141.01% in Q3 2024.
  • Historically, Return on Capital Employed has averaged 76.71% across 5 years, with a median of 69.04% in 2023.
  • The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 7311 bps in 2024, then jumped 2566 bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 39.77% in 2022, then sank by 74 bps to 69.04% in 2023, then tumbled by 30 bps to 89.99% in 2024, then retreated by 21 bps to 109.1% in 2025, then gained by 8 bps to 99.87% in 2026.
  • The last three Return on Capital Employed figures came in at 99.87% (Q1 2026), 109.1% (Q4 2025), and 115.35% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 450.31%
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 51.73%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -107.40%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 21.10%
9 Abivax 91.96 Bn 91.96 Bn - -50.43%
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - -99.87%

Historic Data

Download Data
DateValue
Mar 31, 2026 -99.87%
Dec 31, 2025 -109.10%
Sep 30, 2025 -115.35%
Jun 30, 2025 -99.99%
Mar 31, 2025 -67.07%
Dec 31, 2024 -89.99%
Sep 30, 2024 -141.01%
Jun 30, 2024 -97.91%
Mar 31, 2024 -75.18%
Dec 31, 2023 -69.04%
Sep 30, 2023 -67.90%
Jun 30, 2023 -59.48%
Mar 31, 2023 -54.13%
Dec 31, 2022 -39.77%
Sep 30, 2022 -34.62%
Jun 30, 2022 -40.19%
Mar 31, 2022 -43.54%
Dec 31, 2021 -54.79%
Sep 30, 2021 -48.15%
Jun 30, 2021 -38.38%